RPSAP66

Across TCGA pan-cancer cohorts, RPSAP66 RNA is linked to patient survival in 14 of 34 cancer types, making it the most broadly survival-associated RPSAP66 data layer.

The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where higher RPSAP66 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RPSAP66 expression acts as an unfavorable survival marker, although some lineages such as KIRP and LIHC show a favorable association.

PAAD, UCEC, and LUSC are the cancer types where RPSAP66 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PAAD	DFS	Tertile	All	0.195	0.511	<.001	72	view →
UCEC	OS	Tertile	III,IV	0.721	0.862	.009	52	view →
LUSC	OS	Tertile	III,IV	0.428	0.750	<.001	36	view →
ESCA	DFS	Tertile	All	0.340	1.000	<.001	33	view →
BRCA	OS	Tertile	II,III,IV	0.861	0.925	.004	31	view →
DLBC	OS	Tertile	III,IV	0.175	0.874	.025	27	view →
KIRP	DFS	Tertile	III,IV	0.835	0.278	.023	23	view →
KICH	OS	Tertile	All	0.752	0.981	.013	21	view →
COAD	DFS	Tertile	III,IV	0.472	0.695	.015	15	view →
READ	OS	Tertile	IV	0.508	0.798	.048	6	view →
LIHC	OS	Tertile	All	0.651	0.444	.035	6	view →
THYM	DFS	Tertile	All	0.988	0.871	.035	3	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 14 lineages.

RPSAP66–PAAD (DFS)

Open the PAAD breakdown →